{"id":3321,"date":"2023-04-26T09:47:06","date_gmt":"2023-04-26T09:47:06","guid":{"rendered":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/?p=3321"},"modified":"2023-04-26T10:37:22","modified_gmt":"2023-04-26T10:37:22","slug":"funding-successes-q1-2023","status":"publish","type":"post","link":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/2023\/04\/26\/funding-successes-q1-2023\/","title":{"rendered":"Funding successes: Q1 2023"},"content":{"rendered":"
\n\t\t\t\t\t\n\t\t\t\t\t\t\"Fb-Button\"\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>
<\/fb:like><\/div><\/div>
\"\"<\/a>
Congratulations to Professor George Hanna on his recent funding success.<\/figcaption><\/figure>\n


\nWell done to all Principal Investigators and teams in the Department who have recently been awarded research grants. Here is our quarterly round-up of funding successes.*
\n<\/b><\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Proposal Dept\/Group<\/strong><\/td>\nInfoed PI Name<\/strong><\/td>\nInfoed Sponsor<\/strong><\/td>\nInfoed Proposal Title<\/strong><\/td>\nInfoed Awarded Value (\u00a3)**<\/strong><\/td>\n<\/tr>\n
Anaesthetics<\/td>\nPadmanabhan Ramnarayan<\/td>\nNIHR National Institute for Health Research<\/td>\nA Randomised Multiple Centre Trial of Conservative versus Liberal Oxygenation Targets in Critically Ill Children (Oxy-PICU)<\/td>\n\u00a35,019.62<\/td>\n<\/tr>\n
Anaesthetics<\/td>\nPadmanabhan Ramnarayan<\/td>\nNIHR National Institute for Health Research<\/td>\nEvaluating the clinical and cost effectiveness of using a more permissive blood pressure target to guide careful titration of vasoactive agents in critically ill children with hypotension: PRotocolised Evaluation of PermiSSive hypotension versus Usual care (PRESSURE)<\/td>\n\u00a39,094.09<\/td>\n<\/tr>\n
Cancer<\/td>\nDavid Pinato<\/td>\nImperial College Healthcare NHS Trust<\/td>\nAn artificial intelligence-based approach to identify immunologic predictors of outcome to immunotherapy in hepatocellular cancer using digital pathology<\/td>\n\u00a319,966.00<\/td>\n<\/tr>\n
Cancer<\/td>\nDavid Pinato<\/td>\nThe Foundation for Liver Research<\/td>\nMolecular and immune correlates of response to neoadjuvant immunotherapy in hepatocellular carcinoma (application to Foundation for Liver Research)<\/td>\n\u00a320,000.00<\/td>\n<\/tr>\n
Cancer<\/td>\nJames Flanagan<\/td>\nCRUK Cancer Research UK<\/td>\nCombining diet and symptom management for earlier detection of cancer using transactional data<\/td>\n\u00a386,230.66<\/td>\n<\/tr>\n
Cancer<\/td>\nOlivier Pardo<\/td>\nJune Hancock Mesothelioma Research Fund<\/td>\nValidation of a novel therapeutic strategy and associated response biomarkers for replacing current standard-of-care in mesothelioma treatment (application to UK Charity funder : June Hancock Mesothelioma Research Fund)<\/td>\n\u00a3291,203.28<\/td>\n<\/tr>\n
Cancer<\/td>\nIain McNeish<\/td>\nImperial College Healthcare NHS Trust- BRC Funding<\/td>\nTissue Bank BRC funding 2022-27<\/td>\n\u00a31,572,649.86<\/td>\n<\/tr>\n
General Surgery<\/td>\nDaniel Elson<\/td>\nEPSRC Engineering & Physical Sciences Research Council<\/td>\nTranslational nanoconstructs for targeted tissue accumulation and guided surgery in cancer<\/td>\n\u00a3547,988.00<\/td>\n<\/tr>\n
Musculoskeletal<\/td>\nAlison McGregor<\/td>\nInnovate UK<\/td>\nWearable Devices To Support Prehab<\/td>\n\u00a3115,548.73<\/td>\n<\/tr>\n
OG<\/td>\nMelody Zhifang Ni<\/td>\nInnovate UK<\/td>\nProspective Evaluation of Artificial Intelligence R&D tool for patient stratification in Pancreatic and Liver cancers (PEAR-PAL)<\/td>\n\u00a324,955.00<\/td>\n<\/tr>\n
OG<\/td>\nGeorge Hanna<\/td>\nBASO – The Association for Cancer Surgery<\/td>\nAssessment of the fungal mycobiome and its associated volatile organic compounds for the earlier detection of\u00a0 Oesophagogastric cancer<\/td>\n\u00a349,642.00<\/td>\n<\/tr>\n
OG<\/td>\nGeorge Hanna<\/td>\nPancreatic Cancer UK<\/td>\nVolatile organic compound Assessment in Pancreatic duct adenOcaRcinoma (VAPOR)<\/td>\n\u00a3651,837.52<\/td>\n<\/tr>\n
OG<\/td>\nGeorge Hanna<\/td>\nImperial College Healthcare NHS Trust- BRC Funding<\/td>\nBRC Bioengineering Theme (cost mapping)<\/td>\n\u00a32,336,542.99<\/td>\n<\/tr>\n
Vascular<\/td>\nColin Bicknell<\/td>\nSt Mary’s Coronary Flow Trust<\/td>\nCAVE-ON – Central blood pressure And Variability EvaluatiON: investigating the effect of central BP, aortic stiffness and medication adherence on AAA growth<\/td>\n\u00a318,176.13<\/td>\n<\/tr>\n
Vascular<\/td>\nAlun Davies<\/td>\nNIHR National Institute for Health Research<\/td>\n3 -arm – THRomboprophylaxis in Individuals undergoing superficial endoVEnous therapy (THRIVE), a multi-centre assessor-blind randomised-controlled trial<\/td>\n\u00a32,103,070.30<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

 <\/p>\n

\"\"<\/a>
Congratulations to Professor Amanda Cross on her recent funding success.<\/figcaption><\/figure>\n

 <\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Proposal Dept\/Group<\/strong><\/td>\nInfoed PI Name<\/strong><\/td>\nInfoed Sponsor<\/strong><\/td>\nInfoed Proposal Title<\/strong><\/td>\nInfoed Awarded Value (\u00a3)**<\/strong><\/td>\n<\/tr>\n
Anaesthetics<\/td>\nPadmanabhan Ramnarayan<\/td>\nNIHR National Institute for Health Research<\/td>\nFIRST-line support for Assistance in Breathing in Children: a master protocol of two randomised trails to evaluate the non-inferiority of high flow nasal cannula respiratory support in paediatiric critical care<\/td>\n\u00a316,658.58<\/td>\n<\/tr>\n
Cancer<\/td>\nIain McNeish<\/td>\nOvarian Cancer Action<\/td>\nBRITROC-2 (University of Glasgow, originating Ovarian Cancer Action)<\/td>\n\u00a322,608.00<\/td>\n<\/tr>\n
Cancer<\/td>\nIain McNeish<\/td>\nGenome Research Limited<\/td>\nWellcome Sanger Institute<\/td>\n\u00a369,888.00<\/td>\n<\/tr>\n
Cancer<\/td>\nIain McNeish<\/td>\nFondazione AIRC per la ricerca sul cancro ETS<\/td>\nCopy number alterations and underlying active mutational processes in ovarian high grade serous carcinoma (Fondazione Gianni Bonadonna Fellowship application for Dr Gaia Giannone, 2021).<\/td>\n\u00a3166,667.11<\/td>\n<\/tr>\n
Cancer<\/td>\nOlivier Pardo<\/td>\nWorldwide Cancer Research<\/td>\nResolving the isoform-specific biological role and signalling of RSK1 and RSK4 in cancer<\/td>\n\u00a3249,791.00<\/td>\n<\/tr>\n
Cancer<\/td>\nKirill Veselkov<\/td>\nEU Underwrite – Innovate UK<\/td>\nAn artificially intelligent diagnostic assistant for gastric inflammation<\/td>\n\u00a3809,947.00<\/td>\n<\/tr>\n
Cancer<\/td>\nIain McNeish<\/td>\nImperial College Healthcare NHS Trust- BRC Funding<\/td>\nImperial BRC Renewal 2022-27 – Surgery & Cancer Theme<\/td>\n\u00a33,003,529.67<\/td>\n<\/tr>\n
OG<\/td>\nGwen Murphy<\/td>\nCRUK Cancer Research UK<\/td>\nSerologic biomarkers of stomach cancer precursor lesions<\/td>\n\u00a3100,000.00<\/td>\n<\/tr>\n
OG<\/td>\nPatrick Kierkegaard<\/td>\nPancreatic Cancer UK<\/td>\nA Readiness Assessment and Optimisation Toolkit to Support General Practices Prepare to Adopt New Non-Invasive Pancreatic Cancer Biomarker Tests<\/td>\n\u00a395,509.23<\/td>\n<\/tr>\n
Surgery<\/td>\nAmanda Cross<\/td>\nCRUK Cancer Research UK<\/td>\nScreening, Prevention And Diagnosis Of Gastrointestinal Cancer<\/td>\n\u00a32,297,920.46<\/td>\n<\/tr>\n
Urology<\/td>\nErik Mayer<\/td>\nImperial College Healthcare NHS Trust- BRC Funding<\/td>\niCARE2023 (BRC funding)<\/td>\n\u00a31,422,087.78<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

 <\/p>\n

\"\"<\/a><\/p>\n

Congratulations to Dr Ehsan Ghorani on his recent funding success.<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Proposal Dept\/Group<\/strong><\/td>\nInfoed PI Name<\/strong><\/td>\nInfoed Sponsor<\/strong><\/td>\nInfoed Proposal Title<\/strong><\/td>\nInfoed Awarded Value (\u00a3)**<\/strong><\/td>\n<\/tr>\n
Cancer<\/td>\nSadaf Ghaem-Maghami<\/td>\nWellbeing of Women<\/td>\nInvestigation of use of REIMS tissue analysis to determine HRD status in ovarian cancer<\/td>\n\u00a320,000.00<\/td>\n<\/tr>\n
Cancer<\/td>\nSadaf Ghaem-Maghami<\/td>\nIC New Funder<\/td>\nInvestigation of DCAF15 amplification as a therapeutic target to unleash local anti-tumour immunity Investigation of DCAF15 amplification as a therapeutic target to unleash local anti-tumour immunity (application to Target Ovarian Cancer)<\/td>\n\u00a3229,999.38<\/td>\n<\/tr>\n
Cancer<\/td>\nCharlotte Bevan<\/td>\nProstate Cancer UK<\/td>\nUsing novel stromal cell populations\/characteristics in the prognosis of patients with prostate cancer (EoI , research innovation awards)<\/td>\n\u00a3479,385.01<\/td>\n<\/tr>\n
Cancer<\/td>\nEhsan Ghorani<\/td>\nCRUK Cancer Research UK<\/td>\nDeciphering mechanisms of immune dysfunction and immunotherapy sensitivity in gestational trophoblastic neoplasia<\/td>\n\u00a31,316,113.98<\/td>\n<\/tr>\n
General Surgery<\/td>\nAra Darzi<\/td>\nImperial College Healthcare NHS Trust<\/td>\n2nd – Applying behavioural insights to reduce inequities in outpatient DNA rates<\/td>\n\u00a320,000.00<\/td>\n<\/tr>\n
OG<\/td>\nPatrick Kierkegaard<\/td>\nImperial College Healthcare NHS Trust<\/td>\nImplementation, transferability, and sustainability of the North West London Clinical Trials Alliance model<\/td>\n\u00a316,108.62<\/td>\n<\/tr>\n
OG<\/td>\nPatrick Kierkegaard<\/td>\nCRUK Cancer Research UK<\/td>\nDeveloping an equity-focused Target Product Profile for non-invasive biomarker tests tailored support mobile testing outreach programmes to reduce cancer inequalities<\/td>\n\u00a380,636.83<\/td>\n<\/tr>\n
OG<\/td>\nMelody Zhifang Ni<\/td>\nNHS England<\/td>\nLiquid Biopsies for Faster Diagnosis of Pancreatic and Biliary Tract Cancers<\/td>\n\u00a3170,499.45<\/td>\n<\/tr>\n
Urology<\/td>\nErik Mayer<\/td>\nImperial College Healthcare NHS Trust- BRC Funding<\/td>\nBRC Digital Health Theme S&C<\/td>\n\u00a31,857,877.87<\/td>\n<\/tr>\n
Vascular<\/td>\nAlun Davies<\/td>\nNIHR National Institute for Health Research<\/td>\nVEINS<\/td>\n\u00a3202,724.87<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

** This is the total project value, including subprojects.<\/span><\/span><\/p>\n

*Dude, where\u2019s my grant? A disclaimer:<\/strong><\/p>\n

To ensure the quality and accuracy of the information published on this blog, we source our data directly from the College\u2019s strategic reporting dashboards, relating to FoM. This means that, typically, we only include awards on this list which have been set up on the College\u2019s grants management system, in accordance with the Joint Research Office\u2019s policies and processes. As a result, there may be a delay in promoting some awards.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"

Well done to all Principal Investigators and teams in the Department who have recently been awarded research grants. Here is our quarterly round-up of funding successes.*<\/p>\n","protected":false},"author":1648,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-3321","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"yoast_head":"\nFunding successes: Q1 2023 - S&C Staff Blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/2023\/04\/26\/funding-successes-q1-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Funding successes: Q1 2023 - S&C Staff Blog\" \/>\n<meta property=\"og:description\" content=\"Well done to all Principal Investigators and teams in the Department who have recently been awarded research grants. Here is our quarterly round-up of funding successes.*\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/2023\/04\/26\/funding-successes-q1-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"S&C Staff Blog\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-26T09:47:06+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-04-26T10:37:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/files\/2023\/04\/220720_DG_AHSC_George_Hanna_029-1024x683.jpg\" \/>\n<meta name=\"author\" content=\"Dorcas Ishaya\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ImperialSandC\" \/>\n<meta name=\"twitter:site\" content=\"@ImperialSandC\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dorcas Ishaya\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/2023\\\/04\\\/26\\\/funding-successes-q1-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/2023\\\/04\\\/26\\\/funding-successes-q1-2023\\\/\"},\"author\":{\"name\":\"Dorcas Ishaya\",\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/#\\\/schema\\\/person\\\/ff4b69c6f0533060c5af6cc272245fc9\"},\"headline\":\"Funding successes: Q1 2023\",\"datePublished\":\"2023-04-26T09:47:06+00:00\",\"dateModified\":\"2023-04-26T10:37:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/2023\\\/04\\\/26\\\/funding-successes-q1-2023\\\/\"},\"wordCount\":997,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/2023\\\/04\\\/26\\\/funding-successes-q1-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/files\\\/2023\\\/04\\\/220720_DG_AHSC_George_Hanna_029-1024x683.jpg\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/2023\\\/04\\\/26\\\/funding-successes-q1-2023\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/2023\\\/04\\\/26\\\/funding-successes-q1-2023\\\/\",\"url\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/2023\\\/04\\\/26\\\/funding-successes-q1-2023\\\/\",\"name\":\"Funding successes: Q1 2023 - S&C Staff Blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/2023\\\/04\\\/26\\\/funding-successes-q1-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/2023\\\/04\\\/26\\\/funding-successes-q1-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/files\\\/2023\\\/04\\\/220720_DG_AHSC_George_Hanna_029-1024x683.jpg\",\"datePublished\":\"2023-04-26T09:47:06+00:00\",\"dateModified\":\"2023-04-26T10:37:22+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/#\\\/schema\\\/person\\\/ff4b69c6f0533060c5af6cc272245fc9\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/2023\\\/04\\\/26\\\/funding-successes-q1-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/2023\\\/04\\\/26\\\/funding-successes-q1-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/2023\\\/04\\\/26\\\/funding-successes-q1-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/files\\\/2023\\\/04\\\/220720_DG_AHSC_George_Hanna_029.jpg\",\"contentUrl\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/files\\\/2023\\\/04\\\/220720_DG_AHSC_George_Hanna_029.jpg\",\"width\":1920,\"height\":1280,\"caption\":\"Professor George Hanna, Head of Department of Surgery and Cancer and Consultant General Surgeon at Imperial College Healthcare NHS Trust\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/2023\\\/04\\\/26\\\/funding-successes-q1-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Funding successes: Q1 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/#website\",\"url\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/\",\"name\":\"S&C Staff Blog\",\"description\":\"Surgery and Cancer community news\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/#\\\/schema\\\/person\\\/ff4b69c6f0533060c5af6cc272245fc9\",\"name\":\"Dorcas Ishaya\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ec7570fdc8b829a5a06350c184e7cfa0d70fe17f33a9766dda54d0ea25cbfae2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ec7570fdc8b829a5a06350c184e7cfa0d70fe17f33a9766dda54d0ea25cbfae2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ec7570fdc8b829a5a06350c184e7cfa0d70fe17f33a9766dda54d0ea25cbfae2?s=96&d=mm&r=g\",\"caption\":\"Dorcas Ishaya\"},\"url\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/author\\\/dishaya\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Funding successes: Q1 2023 - S&C Staff Blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/2023\/04\/26\/funding-successes-q1-2023\/","og_locale":"en_US","og_type":"article","og_title":"Funding successes: Q1 2023 - S&C Staff Blog","og_description":"Well done to all Principal Investigators and teams in the Department who have recently been awarded research grants. Here is our quarterly round-up of funding successes.*","og_url":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/2023\/04\/26\/funding-successes-q1-2023\/","og_site_name":"S&C Staff Blog","article_published_time":"2023-04-26T09:47:06+00:00","article_modified_time":"2023-04-26T10:37:22+00:00","og_image":[{"url":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/files\/2023\/04\/220720_DG_AHSC_George_Hanna_029-1024x683.jpg","type":"","width":"","height":""}],"author":"Dorcas Ishaya","twitter_card":"summary_large_image","twitter_creator":"@ImperialSandC","twitter_site":"@ImperialSandC","twitter_misc":{"Written by":"Dorcas Ishaya","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/2023\/04\/26\/funding-successes-q1-2023\/#article","isPartOf":{"@id":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/2023\/04\/26\/funding-successes-q1-2023\/"},"author":{"name":"Dorcas Ishaya","@id":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/#\/schema\/person\/ff4b69c6f0533060c5af6cc272245fc9"},"headline":"Funding successes: Q1 2023","datePublished":"2023-04-26T09:47:06+00:00","dateModified":"2023-04-26T10:37:22+00:00","mainEntityOfPage":{"@id":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/2023\/04\/26\/funding-successes-q1-2023\/"},"wordCount":997,"commentCount":0,"image":{"@id":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/2023\/04\/26\/funding-successes-q1-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/files\/2023\/04\/220720_DG_AHSC_George_Hanna_029-1024x683.jpg","inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/2023\/04\/26\/funding-successes-q1-2023\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/2023\/04\/26\/funding-successes-q1-2023\/","url":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/2023\/04\/26\/funding-successes-q1-2023\/","name":"Funding successes: Q1 2023 - S&C Staff Blog","isPartOf":{"@id":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/#website"},"primaryImageOfPage":{"@id":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/2023\/04\/26\/funding-successes-q1-2023\/#primaryimage"},"image":{"@id":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/2023\/04\/26\/funding-successes-q1-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/files\/2023\/04\/220720_DG_AHSC_George_Hanna_029-1024x683.jpg","datePublished":"2023-04-26T09:47:06+00:00","dateModified":"2023-04-26T10:37:22+00:00","author":{"@id":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/#\/schema\/person\/ff4b69c6f0533060c5af6cc272245fc9"},"breadcrumb":{"@id":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/2023\/04\/26\/funding-successes-q1-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/2023\/04\/26\/funding-successes-q1-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/2023\/04\/26\/funding-successes-q1-2023\/#primaryimage","url":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/files\/2023\/04\/220720_DG_AHSC_George_Hanna_029.jpg","contentUrl":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/files\/2023\/04\/220720_DG_AHSC_George_Hanna_029.jpg","width":1920,"height":1280,"caption":"Professor George Hanna, Head of Department of Surgery and Cancer and Consultant General Surgeon at Imperial College Healthcare NHS Trust"},{"@type":"BreadcrumbList","@id":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/2023\/04\/26\/funding-successes-q1-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/"},{"@type":"ListItem","position":2,"name":"Funding successes: Q1 2023"}]},{"@type":"WebSite","@id":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/#website","url":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/","name":"S&C Staff Blog","description":"Surgery and Cancer community news","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/#\/schema\/person\/ff4b69c6f0533060c5af6cc272245fc9","name":"Dorcas Ishaya","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/ec7570fdc8b829a5a06350c184e7cfa0d70fe17f33a9766dda54d0ea25cbfae2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/ec7570fdc8b829a5a06350c184e7cfa0d70fe17f33a9766dda54d0ea25cbfae2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ec7570fdc8b829a5a06350c184e7cfa0d70fe17f33a9766dda54d0ea25cbfae2?s=96&d=mm&r=g","caption":"Dorcas Ishaya"},"url":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/author\/dishaya\/"}]}},"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/wp-json\/wp\/v2\/posts\/3321","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/wp-json\/wp\/v2\/users\/1648"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/wp-json\/wp\/v2\/comments?post=3321"}],"version-history":[{"count":7,"href":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/wp-json\/wp\/v2\/posts\/3321\/revisions"}],"predecessor-version":[{"id":3334,"href":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/wp-json\/wp\/v2\/posts\/3321\/revisions\/3334"}],"wp:attachment":[{"href":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/wp-json\/wp\/v2\/media?parent=3321"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/wp-json\/wp\/v2\/categories?post=3321"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/wp-json\/wp\/v2\/tags?post=3321"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}